SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+2.8%Nov 18 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOEBT1 who wrote (11357)11/18/1997 1:45:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
JOEBT1, Your list of upcoming announcements certainly suggests that LGND's move this year could be significantly stronger than last year, so its probably worth making a comparision between the two years.

Last year at the end of August, LGND announced the start of the 3 Phase III clinical trials for treating CTCL with topical or oral Targretin. In September they presented at Bear Stearns and made the announcements that gave birth to this thread, the use of Targretin to prevent and treat breast cancer and type II diabetes. On Sept 25 they announced a secondary and a month later they announced the completion of the offering. In Nov, they just announced 3Q results.

This year the recent announcements have been significant. At the end of August, LGND announced the halt of the International Phase III Panretin trial for KS. That was followed by more advanced data on treatment of APL with oral Panretin. Later in September, they announced the splitting up of the ALRT assets, and at the end of the month they announced the impressive data for oral Tragretin treatment of CTCL. On Oct 20, they announced the LLY diabetes deal.

I think that a comparision of the press releases a year apart begins to show what kind of progress LGND has made and a comarision between last year's Dec and Jan news compared with news forcasted for the upcoming two months shows what kind of price movement that can be expected.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News